Laurent Humeau - 20 May 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Scientific Officer
Signature
/s/ Laurent Humeau
Issuer symbol
INO
Transactions as of
20 May 2025
Net transactions value
$0
Form type
4
Filing time
21 May 2025, 16:58:48 UTC
Previous filing
16 May 2025
Next filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Humeau Laurent Chief Scientific Officer C/O INOVIO PHARMACEUTICALS, INC., 6769 MESA RIDGE RD., SAN DIEGO /s/ Laurent Humeau 21 May 2025 0001770390

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Award $0 +18,081 $0.000000 18,081 20 May 2025 Common Stock 18,081 Direct F1
transaction INO Common Stock Option Award $0 +22,419 $0.000000 22,419 20 May 2025 Common Stock 22,419 $2.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 18,081 restricted stock units is as follows: 6,027 shares will vest on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The vesting schedule for the 22,419 options is as follows: 11,210 shares will vest on May 20, 2027 and 11,209 shares will vest on May 20, 2028.